| Literature DB >> 35884098 |
Mulemba Tillika Samutela1,2, Bruno Stephen July Phiri3, Edgar Simulundu4,5, Geoffrey Kwenda1, Ladslav Moonga2, Eugene C Bwalya6, Walter Muleya7, Therese Nyirahabimana7, Kaunda Yamba4,8, Henson Kainga4,9, Simegnew Adugna Kallu4,10, Innocent Mwape11, Andrew Frey12, Matthew Bates13, Hideaki Higashi14, Bernard Mudenda Hang'ombe2.
Abstract
Pigs have been shown to be a reservoir for recently emerging livestock-associated Staphylococcus aureus (LA-SA), including methicillin resistant strains in many countries worldwide. However, there is sparse information about LA-SA strains circulating in Zambia. This study investigated the prevalence, phenotypic and genotypic characteristics of S. aureus from pigs and workers at farms and abattoirs handling pigs in Lusaka Province of Zambia. A total of 492 nasal pig swabs, 53 hand and 53 nasal human swabs were collected from farms and abattoirs in selected districts. Standard microbiological methods were used to isolate and determine antimicrobial susceptibility patterns of S. aureus. Polymerase Chain Reaction was used to confirm the species identity and detect antimicrobial resistance and virulence genes of isolates, whereas genetic diversity was evaluated using spa typing. Overall prevalence of S. aureus was 33.1%, 37.8% for pigs and 11.8% for humans. The isolates were resistant to several antibiotics with resistance ranging from 18% to 98% but were all susceptible to vancomycin. Typical LA-SA spa types were detected. The presence of plasmid mediated resistance genes such as tetM (12.8%), other resistance determinants and immune evasion cluster genes among the isolates is of great public health concern. Thus, continuous surveillance of S. aureus using a "One health" approach is warranted to monitor S.aureus infections and spread of antimicrobial resistance.Entities:
Keywords: Staphylococcus aureus; Zambia; antimicrobial resistance; spa typing; swine
Year: 2022 PMID: 35884098 PMCID: PMC9311834 DOI: 10.3390/antibiotics11070844
Source DB: PubMed Journal: Antibiotics (Basel) ISSN: 2079-6382
S. aureus positivity rates from pigs, humans and districts in Lusaka Province.
| Factor | Category | Prevalence (%) | 95% CI | ||
|---|---|---|---|---|---|
| Overall Positivity | Positive | 598 | 198 | 33.1 | 29.4–37.1 |
| Humans | Overall | 106 | 12 | 11.3 | 6.2–19.3 |
| Hand Swabs | 53 | 6 | 11.3 | 4.7–23.7 | |
| Nasal Swabs | 53 | 6 | 11.3 | 4.7–23.7 | |
| Pigs | Nasal swabs | 492 | 186 | 37.8 | 33.5–42.3 |
| Districts | Chongwe | 250 | 60 | 24.0 | 18.9–29.9 |
| Lusaka | 235 | 63 | 26.8 | 21.4–33.0 | |
| Chilanga | 113 | 75 | 66.4 | 56.6–74.8 |
Abbreviations: CI = Confidence interval; n = number of samples.
Prevalence of S. aureus in pigs and humans at farms and abattoirs.
| Study Site | Species | Type of Facility * | Prevalence (%) | 95% CI | ||
|---|---|---|---|---|---|---|
| Farms | Combined pigs and humans | Small | 53 | 13 | 24.5 | 14.2–38.6 |
| Medium | 252 | 61 | 24.2 | 19.1–30.1 | ||
| Large | 202 | 64 | 31.7 | 25.4–38.7 | ||
| Overall | 507 | 138 | 27.2 | 23.4–31.3 | ||
| Pigs only | Small | 45 | 13 | 28.9 | 16.8–44.5 | |
| Medium | 216 | 57 | 26.4 | 20.8–32.9 | ||
| Large | 157 | 61 | 38.9 | 31.8–47.0 | ||
| Overall | 418 | 131 | 31.3 | 27.0–36.1 | ||
| Humans only | Nasal | 38 | 3 | 7.9 | 2.1–22.5 | |
| Hand | 38 | 4 | 10.5 | 3.4–25.7 | ||
| Overall | 76 | 7 | 9.2 | 4.1–18.6 | ||
| Human Nasal | Small | 4 | 0 | 0 | 0 | |
| Medium | 18 | 2 | 11.1 | 2.0–36.1 | ||
| Large | 16 | 1 | 6.3 | 0.3–32.3 | ||
| Human Hand | Small | 4 | 0 | 0 | 0 | |
| Medium | 18 | 2 | 11.1 | 2.0–36.1 | ||
| Large | 16 | 2 | 12.5 | 2.2–39.6 | ||
| Abattoirs | Combined pigs and humans | Medium | 20 | 4 | 20 | 6.6–44.3 |
| Large | 71 | 56 | 78.9 | 67.3–87.3 | ||
| Overall | 91 | 60 | 65.9 | 55.2–75.3 | ||
| Pigs only | Medium | 20 | 4 | 20 | 6.6–44.3 | |
| Large | 54 | 51 | 94.4 | 83.7–98.6 | ||
| Overall | 71 | 55 | 77.5 | 65.7–86.2 | ||
| Humans ** | Hand | 8 | 2 | 25 | 4. 5–64.4 | |
| Nasal | 9 | 3 | 33.3 | 9.0–69.1 | ||
| Overall | 17 | 5 | 29.4 | 11.4–56.0 |
* Type of facility: Small scale (less than 100 pigs), medium scale (100 to 500 pigs) and commercial scale (greater than 500 pigs; ** All human swabs from abattoirs were collected at the large facilities only. Abbreviations: CI = Confidence interval; n = number of samples.
Figure 1Overall Antimicrobial Susceptibility Profiles of S. aureus Isolates from pigs and workers from Farms (A) and Abattoirs (B) of Lusaka Province. Abbreviations: P = Penicillin; CN = Gentamicin; E = Erythromycin; CD = Clindamycin; Cip = Ciprofloxacin; Te = Tetracycline, SXT = Cotrimoxazole, C = Chloramphenicol, CX = Cefoxitin; I = Intermediate, R = Resistant, S = Susceptible.
Antibiotic resistance patterns of S. aureus isolates from pigs and workers from pig farms and abattoirs in Lusaka Province.
| Resistance Pattern | Proportion of Isolates % ( | |
|---|---|---|
| Farm Isolates ( | Abattoir Isolates ( | |
| P | 34.8 (49) | 42.9 (27) |
| Te | 1.4 (2) | 1.6 (1) |
| P + Te | 20.6 (29) | 7.9 (5) |
| P + Cip | 7.1 (10) | 34.9 (22) |
| P + CD | 0.7 (1) | 3.3 (2) |
| P + CN + Te | 2.1 | 1.6 (1) |
| P + E + TE | 1.4 (2) | - |
| P + Te + Cip | 0.7 (1) | 3.2 (2) |
| P + E + CD + Cip | 14.2 (20) | - |
| P + E + CD + TE | 1.4 (2) | - |
| P + E + C + CIP | 1.4 (2) | - |
| P + CN + TE + SXT | 5.0 (7) | - |
| P + E + CD + TE + SXT | 0.7 (1) | - |
| P + E + CD + CN + Cip | 1.4 (2) | - |
| P + E + CN + Te + CIP | 0.7 (1) | - |
| P + E + CD + CN + Te + SXT | 0.7 (1) | - |
| 1 Other | 4.3 (6) | 4.7 (3) |
Abbreviations: n = number of samples, P = Penicillin; CN = Gentamicin; E = Erythromycin; CD = Clindamycin; Cip = Ciprofloxacin; Te = Tetracycline, SXT = Cotrimoxazole, C = Chloramphenicol, - = Not detected; 1 Other = P + E, P + SXT, P + E + C, P + E + CD, P + E + SXT, P + CD + Te (farm isolates) and P + Te + SXT, P + CD + CN, P + C + Cip (Abattoir isolates). Each pattern was manifested in only one isolate.
IEC genes distribution among the S. aureus isolates (n = 225).
| IEC Gene | ||||
|---|---|---|---|---|
| Source (Farm or Abattoir) | Sample Type | |||
| Farm 1 | Pig nasal Swab | - | 0.4 (1) | - |
| Farm 2 | Pig nasal Swab | - | 0.4 (1) | - |
| Farm 4 | Pig nasal Swab | - | 1.3 (3) | - |
| Farm 5 | Pig nasal Swab | - | 0.4 (1) | - |
| Farm 6 | Pig nasal Swab | - | 0.4 (1) | - |
| Farm 7 | Pig nasal Swab | 0.9 (2) | 2.7 (6) | - |
| Farm 9 | Pig nasal Swab | - | 0.4 (1) | - |
| Farm 10 | Pig nasal Swab | - | 1.3 (3) | - |
| Abattoir 1 | Pig nasal Swab | 0.4 (1) | - | 0.4 (1) |
| Total | 1.3 (3) | 7.6 (17) | 0.4 (1) | |
Abbreviation: n = number of isolates; - = None detected.
Spa type distribution among representative farm and abattoir isolates (n = 43).
| Species | Study Site | t1430 | t034 | t318 | t571 | t084 | t899 | Unknown |
| Humans | Farms | 0 | 0 | 0 | 0 | 0 | 2.3 (1) | 4.7 (2) |
| Abattoirs | 4.7 (2) | 0 | 0 | 0 | 2.3 (1) | 0 | 0 | |
| Pigs | Farms | 14.0 (6) | 9.3 (4) | 9.3 (4) | 2.3 (1) | 0 | 0 | 25.6 (11) |
| Abattoirs | 9.3 (4) | 9.3 (4) | 0 | 0 | 0 | 0 | 7.0 (3) | |
| Total | 28.0 (12) | 18.6 (8) | 9.3 (4) | 2.3 (1) | 2.3 (1) | 2.3 (1) | 37.3 (16) | |
Abbreviation: n = number of isolates.
Figure 2Map of the Study Sites Selected from Lusaka province in Zambia; Map was generated using the software ArcGIS version 10.3.
Primer sets used in the study.
| Primer Name | Target Gene | Primer Sequence (5′-3′) | Amplicon Size | Reference |
|---|---|---|---|---|
| Nuc1 |
| GCG ATT GAT GGT GAT ACG GTT | 279 bp | [ |
| Nuc2 | AGC CAA GCC TTG ACG AAC TAA AGC | |||
| mecA P4 | TCCAGATTACAACTTCACCAGG | 162 bp | [ | |
| mecA P7 | CCACTTCATATCTTGTAACG | |||
| mecALGA251 |
| GAAAAAAAGGCTTAGAACGCCTC | 138 bp | [ |
| mecALGA251 | GAAGATCTTTTCCGTTTTCAGC | |||
| ermA-1 | TCTAAAAAGCATGTAAAAGAA | 645 bp | [ | |
| ermA-2 | CTTCGATAGTTTATTAATATTAG | |||
| ermB-1 | GAAAAGTACTCAACCAAATA | 639 bp | [ | |
| ermB-2 | AGTAACGGTACTTAAATTGTTTA | |||
| ermC-1 | TCAAAACATAATATAGATAAA | 642 bp | [ | |
| ermC-2 | GCTAATATTGTTTAAATCGTCAAT | |||
| tetK-1 | TTAGGTGAAGGGTTAGGTCC | 697 bp | [ | |
| tetK-2 | GCAAACTCATTCCAGAAGCA | |||
| tetM-1 | GTTAAATAGTGTTCTTGGAG | 576 bp | [ | |
| tetM-2 | CTAAGATATGGCTCTAACAA | |||
| tetL-1 | CATTTGGTCTTATTGGATCG | 456 bp | [ | |
| tetL-2 | ATTACACTTCCGATTTCGG | |||
| tetO-1 | GATGGCATACAGGCACAGAC | 615 bp | [ | |
| tetO-2 | CAATATCACCAGAGCAGGCT | |||
| pvl-FP |
| GCTGGACAAAACTTCTTGGAATAT | 83 | [ |
| pvl-RP | GATAGGACACCAATAAATTCTGGATTG | |||
| SEA-3 |
| CCTTTGGAAACGGTTAAAACG | 127 bp | [ |
| SEA-4 | TCTGAACCTTCCCATCAAAAAC | |||
| SEB-1 |
| TCGCATCAAACTGACAAACG | 477 bp | [ |
| SEB-4 | GCAGGTACTCTATAAGTGCCTGC | |||
| SEC-3 |
| CTCAAGAACTAGACATAAAAGCTAGG | 271 bp | [ |
| SEC-4 | TCAAAATCGGATTAACATTATCC | |||
| SED-3 |
| CTAGTTTGGTAATATCTCCTTTAAACG | 319 bp | [ |
| SED-4 | TTAATGCTATATCTTATAGGGTAAACATC | |||
| SEE-3 |
| CAGTACCTATAGATAAAGTTAAAACAAGC | 178 bp | [ |
| SEE-2 | TAACTTACCGTGGACCCTTC | |||
| Sak-1 |
| AAGGCGATGACGCGAGTTAT | 223 bp | [ |
| Sak-2 | GCGCTTGGATCTAATTCAAC | |||
| Chp-1 |
| GAAAAAGAAATTAGCAACAACAG | 410 bp | [ |
| Chp-2 | CATAAGATGATTTAGACTCTCC | |||
| Scn-1 |
| AGCACAAGCTTGCCAACATCG | 258 bp | [ |
| Scn-2 | TTAATATTTACTTTTTAGTGC | |||
| 1095F |
| AGACGATCCTTCGGTGAGC | variable | [ |
| 1517R | GCTTTTGCAATGTCATTTACTG |